论文部分内容阅读
自1979年11月苏州医学院血液研究室首创HOAP方案,治疗急性非淋巴细胞白血病(简称急非淋)以来,国内相继有报导。我院从1981年4月起,治疗未加选择的急非淋32例取得满意结果,现分析总结如下。
Since November 1979, Suzhou Medical School Blood Laboratory pioneered HOAP program for the treatment of acute non-lymphocytic leukemia (referred to as acute Fei Lin), have been reported in China. Our hospital from April 1981 onwards, the treatment of unselected acute Fei Lin obtained satisfactory results, the analysis is summarized as follows.